img

Global Evolocumab Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Evolocumab Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Evolocumab(trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia.
Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and its inhibition thereby enhances the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.
Evolocumab report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Evolocumab market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chemical and Pharmaceutical are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Evolocumab industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Evolocumab key manufacturers include BOCSCI, Carbosynth, TargetMol Chemicals, Chemren Bio-Engineering, DC Chemicals, Hefei Enli Medical Technology, Hefei Hirisun Pharmatech, Hubei Kele Fine Chemical and Hubei Xingcheng Biotechnology, etc. BOCSCI, Carbosynth, TargetMol Chemicals are top 3 players and held % sales share in total in 2022.
Evolocumab can be divided into Patent and Generic, etc. Patent is the mainstream product in the market, accounting for % sales share globally in 2022.
Evolocumab is widely used in various fields, such as Chemical and Pharmaceutical, etc. Chemical provides greatest supports to the Evolocumab industry development. In 2022, global % sales of Evolocumab went into Chemical filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Evolocumab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


BOCSCI
Carbosynth
TargetMol Chemicals
Chemren Bio-Engineering
DC Chemicals
Hefei Enli Medical Technology
Hefei Hirisun Pharmatech
Hubei Kele Fine Chemical
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
WeiShi Reagent
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
Segment by Type
Patent
Generic

Segment by Application


Chemical
Pharmaceutical

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Evolocumab market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Evolocumab, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Evolocumab industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Evolocumab in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Evolocumab introduction, etc. Evolocumab Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Evolocumab market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Evolocumab Market Overview
1.1 Evolocumab Product Overview
1.2 Evolocumab Market Segment by Type
1.2.1 Patent
1.2.2 Generic
1.3 Global Evolocumab Market Size by Type
1.3.1 Global Evolocumab Market Size Overview by Type (2024-2034)
1.3.2 Global Evolocumab Historic Market Size Review by Type (2024-2024)
1.3.3 Global Evolocumab Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Evolocumab Sales Breakdown by Type (2024-2024)
1.4.2 Europe Evolocumab Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Evolocumab Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Evolocumab Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Evolocumab Sales Breakdown by Type (2024-2024)
2 Global Evolocumab Market Competition by Company
2.1 Global Top Players by Evolocumab Sales (2024-2024)
2.2 Global Top Players by Evolocumab Revenue (2024-2024)
2.3 Global Top Players by Evolocumab Price (2024-2024)
2.4 Global Top Manufacturers Evolocumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Evolocumab Market Competitive Situation and Trends
2.5.1 Evolocumab Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Evolocumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Evolocumab as of 2022)
2.7 Date of Key Manufacturers Enter into Evolocumab Market
2.8 Key Manufacturers Evolocumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Evolocumab Status and Outlook by Region
3.1 Global Evolocumab Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Evolocumab Historic Market Size by Region
3.2.1 Global Evolocumab Sales in Volume by Region (2024-2024)
3.2.2 Global Evolocumab Sales in Value by Region (2024-2024)
3.2.3 Global Evolocumab Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Evolocumab Forecasted Market Size by Region
3.3.1 Global Evolocumab Sales in Volume by Region (2024-2034)
3.3.2 Global Evolocumab Sales in Value by Region (2024-2034)
3.3.3 Global Evolocumab Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Evolocumab by Application
4.1 Evolocumab Market Segment by Application
4.1.1 Chemical
4.1.2 Pharmaceutical
4.2 Global Evolocumab Market Size by Application
4.2.1 Global Evolocumab Market Size Overview by Application (2024-2034)
4.2.2 Global Evolocumab Historic Market Size Review by Application (2024-2024)
4.2.3 Global Evolocumab Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Evolocumab Sales Breakdown by Application (2024-2024)
4.3.2 Europe Evolocumab Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Evolocumab Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Evolocumab Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Evolocumab Sales Breakdown by Application (2024-2024)
5 North America Evolocumab by Country
5.1 North America Evolocumab Historic Market Size by Country
5.1.1 North America Evolocumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Evolocumab Sales in Volume by Country (2024-2024)
5.1.3 North America Evolocumab Sales in Value by Country (2024-2024)
5.2 North America Evolocumab Forecasted Market Size by Country
5.2.1 North America Evolocumab Sales in Volume by Country (2024-2034)
5.2.2 North America Evolocumab Sales in Value by Country (2024-2034)
6 Europe Evolocumab by Country
6.1 Europe Evolocumab Historic Market Size by Country
6.1.1 Europe Evolocumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Evolocumab Sales in Volume by Country (2024-2024)
6.1.3 Europe Evolocumab Sales in Value by Country (2024-2024)
6.2 Europe Evolocumab Forecasted Market Size by Country
6.2.1 Europe Evolocumab Sales in Volume by Country (2024-2034)
6.2.2 Europe Evolocumab Sales in Value by Country (2024-2034)
7 Asia-Pacific Evolocumab by Region
7.1 Asia-Pacific Evolocumab Historic Market Size by Region
7.1.1 Asia-Pacific Evolocumab Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Evolocumab Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Evolocumab Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Evolocumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Evolocumab Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Evolocumab Sales in Value by Region (2024-2034)
8 Latin America Evolocumab by Country
8.1 Latin America Evolocumab Historic Market Size by Country
8.1.1 Latin America Evolocumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Evolocumab Sales in Volume by Country (2024-2024)
8.1.3 Latin America Evolocumab Sales in Value by Country (2024-2024)
8.2 Latin America Evolocumab Forecasted Market Size by Country
8.2.1 Latin America Evolocumab Sales in Volume by Country (2024-2034)
8.2.2 Latin America Evolocumab Sales in Value by Country (2024-2034)
9 Middle East and Africa Evolocumab by Country
9.1 Middle East and Africa Evolocumab Historic Market Size by Country
9.1.1 Middle East and Africa Evolocumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Evolocumab Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Evolocumab Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Evolocumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Evolocumab Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Evolocumab Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BOCSCI
10.1.1 BOCSCI Company Information
10.1.2 BOCSCI Introduction and Business Overview
10.1.3 BOCSCI Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.1.4 BOCSCI Evolocumab Products Offered
10.1.5 BOCSCI Recent Development
10.2 Carbosynth
10.2.1 Carbosynth Company Information
10.2.2 Carbosynth Introduction and Business Overview
10.2.3 Carbosynth Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Carbosynth Evolocumab Products Offered
10.2.5 Carbosynth Recent Development
10.3 TargetMol Chemicals
10.3.1 TargetMol Chemicals Company Information
10.3.2 TargetMol Chemicals Introduction and Business Overview
10.3.3 TargetMol Chemicals Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.3.4 TargetMol Chemicals Evolocumab Products Offered
10.3.5 TargetMol Chemicals Recent Development
10.4 Chemren Bio-Engineering
10.4.1 Chemren Bio-Engineering Company Information
10.4.2 Chemren Bio-Engineering Introduction and Business Overview
10.4.3 Chemren Bio-Engineering Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Chemren Bio-Engineering Evolocumab Products Offered
10.4.5 Chemren Bio-Engineering Recent Development
10.5 DC Chemicals
10.5.1 DC Chemicals Company Information
10.5.2 DC Chemicals Introduction and Business Overview
10.5.3 DC Chemicals Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.5.4 DC Chemicals Evolocumab Products Offered
10.5.5 DC Chemicals Recent Development
10.6 Hefei Enli Medical Technology
10.6.1 Hefei Enli Medical Technology Company Information
10.6.2 Hefei Enli Medical Technology Introduction and Business Overview
10.6.3 Hefei Enli Medical Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Hefei Enli Medical Technology Evolocumab Products Offered
10.6.5 Hefei Enli Medical Technology Recent Development
10.7 Hefei Hirisun Pharmatech
10.7.1 Hefei Hirisun Pharmatech Company Information
10.7.2 Hefei Hirisun Pharmatech Introduction and Business Overview
10.7.3 Hefei Hirisun Pharmatech Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Hefei Hirisun Pharmatech Evolocumab Products Offered
10.7.5 Hefei Hirisun Pharmatech Recent Development
10.8 Hubei Kele Fine Chemical
10.8.1 Hubei Kele Fine Chemical Company Information
10.8.2 Hubei Kele Fine Chemical Introduction and Business Overview
10.8.3 Hubei Kele Fine Chemical Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hubei Kele Fine Chemical Evolocumab Products Offered
10.8.5 Hubei Kele Fine Chemical Recent Development
10.9 Hubei Xingcheng Biotechnology
10.9.1 Hubei Xingcheng Biotechnology Company Information
10.9.2 Hubei Xingcheng Biotechnology Introduction and Business Overview
10.9.3 Hubei Xingcheng Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Hubei Xingcheng Biotechnology Evolocumab Products Offered
10.9.5 Hubei Xingcheng Biotechnology Recent Development
10.10 Hubei Zhongshan Medical Technology
10.10.1 Hubei Zhongshan Medical Technology Company Information
10.10.2 Hubei Zhongshan Medical Technology Introduction and Business Overview
10.10.3 Hubei Zhongshan Medical Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Hubei Zhongshan Medical Technology Evolocumab Products Offered
10.10.5 Hubei Zhongshan Medical Technology Recent Development
10.11 Nantong Feiyu Biological Technology
10.11.1 Nantong Feiyu Biological Technology Company Information
10.11.2 Nantong Feiyu Biological Technology Introduction and Business Overview
10.11.3 Nantong Feiyu Biological Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Nantong Feiyu Biological Technology Evolocumab Products Offered
10.11.5 Nantong Feiyu Biological Technology Recent Development
10.12 Nantong Hi-Future Biotechnology
10.12.1 Nantong Hi-Future Biotechnology Company Information
10.12.2 Nantong Hi-Future Biotechnology Introduction and Business Overview
10.12.3 Nantong Hi-Future Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Nantong Hi-Future Biotechnology Evolocumab Products Offered
10.12.5 Nantong Hi-Future Biotechnology Recent Development
10.13 Shanghai Biochempartner
10.13.1 Shanghai Biochempartner Company Information
10.13.2 Shanghai Biochempartner Introduction and Business Overview
10.13.3 Shanghai Biochempartner Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Shanghai Biochempartner Evolocumab Products Offered
10.13.5 Shanghai Biochempartner Recent Development
10.14 Shanghai Loulan Biotechnology
10.14.1 Shanghai Loulan Biotechnology Company Information
10.14.2 Shanghai Loulan Biotechnology Introduction and Business Overview
10.14.3 Shanghai Loulan Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Shanghai Loulan Biotechnology Evolocumab Products Offered
10.14.5 Shanghai Loulan Biotechnology Recent Development
10.15 Shanghai Macklin Biochemical
10.15.1 Shanghai Macklin Biochemical Company Information
10.15.2 Shanghai Macklin Biochemical Introduction and Business Overview
10.15.3 Shanghai Macklin Biochemical Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Shanghai Macklin Biochemical Evolocumab Products Offered
10.15.5 Shanghai Macklin Biochemical Recent Development
10.16 Shanghai Minkai Biotechnology
10.16.1 Shanghai Minkai Biotechnology Company Information
10.16.2 Shanghai Minkai Biotechnology Introduction and Business Overview
10.16.3 Shanghai Minkai Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Shanghai Minkai Biotechnology Evolocumab Products Offered
10.16.5 Shanghai Minkai Biotechnology Recent Development
10.17 Shanghai Ruihui Chemical Technology
10.17.1 Shanghai Ruihui Chemical Technology Company Information
10.17.2 Shanghai Ruihui Chemical Technology Introduction and Business Overview
10.17.3 Shanghai Ruihui Chemical Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Shanghai Ruihui Chemical Technology Evolocumab Products Offered
10.17.5 Shanghai Ruihui Chemical Technology Recent Development
10.18 Shanghai Yifei Biotechnology
10.18.1 Shanghai Yifei Biotechnology Company Information
10.18.2 Shanghai Yifei Biotechnology Introduction and Business Overview
10.18.3 Shanghai Yifei Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Shanghai Yifei Biotechnology Evolocumab Products Offered
10.18.5 Shanghai Yifei Biotechnology Recent Development
10.19 Sichuan Weiqi Biotechnology
10.19.1 Sichuan Weiqi Biotechnology Company Information
10.19.2 Sichuan Weiqi Biotechnology Introduction and Business Overview
10.19.3 Sichuan Weiqi Biotechnology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Sichuan Weiqi Biotechnology Evolocumab Products Offered
10.19.5 Sichuan Weiqi Biotechnology Recent Development
10.20 Taizhou KEDE Chemical
10.20.1 Taizhou KEDE Chemical Company Information
10.20.2 Taizhou KEDE Chemical Introduction and Business Overview
10.20.3 Taizhou KEDE Chemical Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Taizhou KEDE Chemical Evolocumab Products Offered
10.20.5 Taizhou KEDE Chemical Recent Development
10.21 Taizhou Kerui Bio-Technology
10.21.1 Taizhou Kerui Bio-Technology Company Information
10.21.2 Taizhou Kerui Bio-Technology Introduction and Business Overview
10.21.3 Taizhou Kerui Bio-Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.21.4 Taizhou Kerui Bio-Technology Evolocumab Products Offered
10.21.5 Taizhou Kerui Bio-Technology Recent Development
10.22 WeiShi Reagent
10.22.1 WeiShi Reagent Company Information
10.22.2 WeiShi Reagent Introduction and Business Overview
10.22.3 WeiShi Reagent Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.22.4 WeiShi Reagent Evolocumab Products Offered
10.22.5 WeiShi Reagent Recent Development
10.23 Wuhan Fortuna Chemical
10.23.1 Wuhan Fortuna Chemical Company Information
10.23.2 Wuhan Fortuna Chemical Introduction and Business Overview
10.23.3 Wuhan Fortuna Chemical Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.23.4 Wuhan Fortuna Chemical Evolocumab Products Offered
10.23.5 Wuhan Fortuna Chemical Recent Development
10.24 Wuhan Sunrise Technology Development
10.24.1 Wuhan Sunrise Technology Development Company Information
10.24.2 Wuhan Sunrise Technology Development Introduction and Business Overview
10.24.3 Wuhan Sunrise Technology Development Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.24.4 Wuhan Sunrise Technology Development Evolocumab Products Offered
10.24.5 Wuhan Sunrise Technology Development Recent Development
10.25 Wuhan Weisman Bioengineering
10.25.1 Wuhan Weisman Bioengineering Company Information
10.25.2 Wuhan Weisman Bioengineering Introduction and Business Overview
10.25.3 Wuhan Weisman Bioengineering Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.25.4 Wuhan Weisman Bioengineering Evolocumab Products Offered
10.25.5 Wuhan Weisman Bioengineering Recent Development
10.26 Wuhan Yingnuo Pharmaceutical Technology
10.26.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
10.26.2 Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
10.26.3 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales, Revenue and Gross Margin (2024-2024)
10.26.4 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Products Offered
10.26.5 Wuhan Yingnuo Pharmaceutical Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Evolocumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Evolocumab Industrial Chain Analysis
11.4 Evolocumab Market Dynamics
11.4.1 Evolocumab Industry Trends
11.4.2 Evolocumab Market Drivers
11.4.3 Evolocumab Market Challenges
11.4.4 Evolocumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Evolocumab Distributors
12.3 Evolocumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Patent
Table 2. Major Company of Generic
Table 3. Global Evolocumab Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Evolocumab Sales by Type (2024-2024) & (Kg)
Table 5. Global Evolocumab Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Evolocumab Sales by Type (2024-2024) & (US& Million)
Table 7. Global Evolocumab Market Share in Value by Type (2024-2024)
Table 8. Global Evolocumab Price by Type (2024-2024) & (US$/Kg)
Table 9. Global Evolocumab Sales by Type (2024-2034) & (Kg)
Table 10. Global Evolocumab Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Evolocumab Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Evolocumab Sales Market Share in Value by Type (2024-2034)
Table 13. Global Evolocumab Price by Type (2024-2034) & (US$/Kg)
Table 14. North America Evolocumab Sales by Type (2024-2024) & (Kg)
Table 15. North America Evolocumab Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Evolocumab Sales (Kg) by Type (2024-2024)
Table 17. Europe Evolocumab Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Evolocumab Sales (Kg) by Type (2024-2024)
Table 19. Asia-Pacific Evolocumab Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Evolocumab Sales (Kg) by Type (2024-2024)
Table 21. Latin America Evolocumab Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Evolocumab Sales (Kg) by Type (2024-2024)
Table 23. Middle East and Africa Evolocumab Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Evolocumab Sales by Company (2024-2024) & (Kg)
Table 25. Global Evolocumab Sales Share by Company (2024-2024)
Table 26. Global Evolocumab Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Evolocumab Revenue Share by Company (2024-2024)
Table 28. Global Market Evolocumab Price by Company (2024-2024) & (US$/Kg)
Table 29. Global Evolocumab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Evolocumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Evolocumab as of 2022)
Table 32. Date of Key Manufacturers Enter into Evolocumab Market
Table 33. Key Manufacturers Evolocumab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Evolocumab Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Evolocumab Sales by Region (2024-2024) & (Kg)
Table 37. Global Evolocumab Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Evolocumab Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Evolocumab Sales Market Share in Value by Region (2024-2024)
Table 40. Global Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 41. Global Evolocumab Sales by Region (2024-2034) & (Kg)
Table 42. Global Evolocumab Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Evolocumab Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Evolocumab Sales Market Share in Value by Region (2024-2034)
Table 45. Global Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 46. Global Evolocumab Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Evolocumab Sales by Application (2024-2024) & (Kg)
Table 48. Global Evolocumab Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Evolocumab Sales Market Share in Value by Application (2024-2024)
Table 51. Global Evolocumab Price by Application (2024-2024) & (US$/Kg)
Table 52. Global Evolocumab Sales by Application (2024-2034) & (Kg)
Table 53. Global Evolocumab Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Evolocumab Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Evolocumab Sales Market Share in Value by Application (2024-2034)
Table 56. Global Evolocumab Price by Application (2024-2034) & (US$/Kg)
Table 57. North America Evolocumab Sales by Application (2024-2024) (Kg)
Table 58. North America Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Evolocumab Sales by Application (2024-2024) (Kg)
Table 60. Europe Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Evolocumab Sales by Application (2024-2024) (Kg)
Table 62. Asia-Pacific Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Evolocumab Sales by Application (2024-2024) (Kg)
Table 64. Latin America Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Evolocumab Sales by Application (2024-2024) (Kg)
Table 66. Middle East and Africa Evolocumab Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Evolocumab Sales by Country (2024-2024) & (Kg)
Table 68. North America Evolocumab Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Evolocumab Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Evolocumab Sales Market Share in Value by Country (2024-2024)
Table 71. North America Evolocumab Sales by Country (2024-2034) & (Kg)
Table 72. North America Evolocumab Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Evolocumab Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Evolocumab Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Evolocumab Sales by Country (2024-2024) & (Kg)
Table 76. Europe Evolocumab Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Evolocumab Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Evolocumab Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Evolocumab Sales by Country (2024-2034) & (Kg)
Table 80. Europe Evolocumab Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Evolocumab Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Evolocumab Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Evolocumab Sales by Region (2024-2024) & (Kg)
Table 84. Asia-Pacific Evolocumab Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Evolocumab Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Evolocumab Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Evolocumab Sales by Region (2024-2034) & (Kg)
Table 88. Asia-Pacific Evolocumab Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Evolocumab Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Evolocumab Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Evolocumab Sales by Country (2024-2024) & (Kg)
Table 92. Latin America Evolocumab Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Evolocumab Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Evolocumab Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Evolocumab Sales by Country (2024-2034) & (Kg)
Table 96. Latin America Evolocumab Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Evolocumab Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Evolocumab Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Evolocumab Sales by Country (2024-2024) & (Kg)
Table 100. Middle East and Africa Evolocumab Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Evolocumab Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Evolocumab Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Evolocumab Sales by Country (2024-2034) & (Kg)
Table 104. Middle East and Africa Evolocumab Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Evolocumab Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Evolocumab Sales Market Share in Value by Country (2024-2034)
Table 107. BOCSCI Company Information
Table 108. BOCSCI Introduction and Business Overview
Table 109. BOCSCI Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 110. BOCSCI Evolocumab Product
Table 111. BOCSCI Recent Development
Table 112. Carbosynth Company Information
Table 113. Carbosynth Introduction and Business Overview
Table 114. Carbosynth Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 115. Carbosynth Evolocumab Product
Table 116. Carbosynth Recent Development
Table 117. TargetMol Chemicals Company Information
Table 118. TargetMol Chemicals Introduction and Business Overview
Table 119. TargetMol Chemicals Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 120. TargetMol Chemicals Evolocumab Product
Table 121. TargetMol Chemicals Recent Development
Table 122. Chemren Bio-Engineering Company Information
Table 123. Chemren Bio-Engineering Introduction and Business Overview
Table 124. Chemren Bio-Engineering Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 125. Chemren Bio-Engineering Evolocumab Product
Table 126. Chemren Bio-Engineering Recent Development
Table 127. DC Chemicals Company Information
Table 128. DC Chemicals Introduction and Business Overview
Table 129. DC Chemicals Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 130. DC Chemicals Evolocumab Product
Table 131. DC Chemicals Recent Development
Table 132. Hefei Enli Medical Technology Company Information
Table 133. Hefei Enli Medical Technology Introduction and Business Overview
Table 134. Hefei Enli Medical Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 135. Hefei Enli Medical Technology Evolocumab Product
Table 136. Hefei Enli Medical Technology Recent Development
Table 137. Hefei Hirisun Pharmatech Company Information
Table 138. Hefei Hirisun Pharmatech Introduction and Business Overview
Table 139. Hefei Hirisun Pharmatech Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 140. Hefei Hirisun Pharmatech Evolocumab Product
Table 141. Hefei Hirisun Pharmatech Recent Development
Table 142. Hubei Kele Fine Chemical Company Information
Table 143. Hubei Kele Fine Chemical Introduction and Business Overview
Table 144. Hubei Kele Fine Chemical Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 145. Hubei Kele Fine Chemical Evolocumab Product
Table 146. Hubei Kele Fine Chemical Recent Development
Table 147. Hubei Xingcheng Biotechnology Company Information
Table 148. Hubei Xingcheng Biotechnology Introduction and Business Overview
Table 149. Hubei Xingcheng Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 150. Hubei Xingcheng Biotechnology Evolocumab Product
Table 151. Hubei Xingcheng Biotechnology Recent Development
Table 152. Hubei Zhongshan Medical Technology Company Information
Table 153. Hubei Zhongshan Medical Technology Introduction and Business Overview
Table 154. Hubei Zhongshan Medical Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 155. Hubei Zhongshan Medical Technology Evolocumab Product
Table 156. Hubei Zhongshan Medical Technology Recent Development
Table 157. Nantong Feiyu Biological Technology Company Information
Table 158. Nantong Feiyu Biological Technology Introduction and Business Overview
Table 159. Nantong Feiyu Biological Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 160. Nantong Feiyu Biological Technology Evolocumab Product
Table 161. Nantong Feiyu Biological Technology Recent Development
Table 162. Nantong Hi-Future Biotechnology Company Information
Table 163. Nantong Hi-Future Biotechnology Introduction and Business Overview
Table 164. Nantong Hi-Future Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 165. Nantong Hi-Future Biotechnology Evolocumab Product
Table 166. Nantong Hi-Future Biotechnology Recent Development
Table 167. Shanghai Biochempartner Company Information
Table 168. Shanghai Biochempartner Introduction and Business Overview
Table 169. Shanghai Biochempartner Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 170. Shanghai Biochempartner Evolocumab Product
Table 171. Shanghai Biochempartner Recent Development
Table 172. Shanghai Loulan Biotechnology Company Information
Table 173. Shanghai Loulan Biotechnology Introduction and Business Overview
Table 174. Shanghai Loulan Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 175. Shanghai Loulan Biotechnology Evolocumab Product
Table 176. Shanghai Loulan Biotechnology Recent Development
Table 177. Shanghai Macklin Biochemical Company Information
Table 178. Shanghai Macklin Biochemical Introduction and Business Overview
Table 179. Shanghai Macklin Biochemical Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 180. Shanghai Macklin Biochemical Evolocumab Product
Table 181. Shanghai Macklin Biochemical Recent Development
Table 182. Shanghai Minkai Biotechnology Company Information
Table 183. Shanghai Minkai Biotechnology Introduction and Business Overview
Table 184. Shanghai Minkai Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 185. Shanghai Minkai Biotechnology Evolocumab Product
Table 186. Shanghai Minkai Biotechnology Recent Development
Table 187. Shanghai Ruihui Chemical Technology Company Information
Table 188. Shanghai Ruihui Chemical Technology Introduction and Business Overview
Table 189. Shanghai Ruihui Chemical Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 190. Shanghai Ruihui Chemical Technology Evolocumab Product
Table 191. Shanghai Ruihui Chemical Technology Recent Development
Table 192. Shanghai Yifei Biotechnology Company Information
Table 193. Shanghai Yifei Biotechnology Introduction and Business Overview
Table 194. Shanghai Yifei Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 195. Shanghai Yifei Biotechnology Evolocumab Product
Table 196. Shanghai Yifei Biotechnology Recent Development
Table 197. Sichuan Weiqi Biotechnology Company Information
Table 198. Sichuan Weiqi Biotechnology Introduction and Business Overview
Table 199. Sichuan Weiqi Biotechnology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 200. Sichuan Weiqi Biotechnology Evolocumab Product
Table 201. Sichuan Weiqi Biotechnology Recent Development
Table 202. Taizhou KEDE Chemical Company Information
Table 203. Taizhou KEDE Chemical Introduction and Business Overview
Table 204. Taizhou KEDE Chemical Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 205. Taizhou KEDE Chemical Evolocumab Product
Table 206. Taizhou KEDE Chemical Recent Development
Table 207. Taizhou Kerui Bio-Technology Company Information
Table 208. Taizhou Kerui Bio-Technology Introduction and Business Overview
Table 209. Taizhou Kerui Bio-Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 210. Taizhou Kerui Bio-Technology Evolocumab Product
Table 211. Taizhou Kerui Bio-Technology Recent Development
Table 212. WeiShi Reagent Company Information
Table 213. WeiShi Reagent Introduction and Business Overview
Table 214. WeiShi Reagent Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 215. WeiShi Reagent Evolocumab Product
Table 216. WeiShi Reagent Recent Development
Table 217. Wuhan Fortuna Chemical Company Information
Table 218. Wuhan Fortuna Chemical Introduction and Business Overview
Table 219. Wuhan Fortuna Chemical Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 220. Wuhan Fortuna Chemical Evolocumab Product
Table 221. Wuhan Fortuna Chemical Recent Development
Table 222. Wuhan Sunrise Technology Development Company Information
Table 223. Wuhan Sunrise Technology Development Introduction and Business Overview
Table 224. Wuhan Sunrise Technology Development Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 225. Wuhan Sunrise Technology Development Evolocumab Product
Table 226. Wuhan Sunrise Technology Development Recent Development
Table 227. Wuhan Weisman Bioengineering Introduction and Business Overview
Table 228. Wuhan Weisman Bioengineering Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 229. Wuhan Weisman Bioengineering Evolocumab Product
Table 230. Wuhan Weisman Bioengineering Recent Development
Table 231. Wuhan Weisman Bioengineering Company Information
Table 232. Wuhan Yingnuo Pharmaceutical Technology Company Information
Table 233. Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
Table 234. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 235. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product
Table 236. Wuhan Yingnuo Pharmaceutical Technology Recent Development
Table 237. Key Raw Materials Lists
Table 238. Raw Materials Key Suppliers Lists
Table 239. Evolocumab Market Trends
Table 240. Evolocumab Market Drivers
Table 241. Evolocumab Market Challenges
Table 242. Evolocumab Market Restraints
Table 243. Evolocumab Distributors List
Table 244. Evolocumab Downstream Customers
Table 245. Research Programs/Design for This Report
Table 246. Key Data Information from Secondary Sources
Table 247. Key Data Information from Primary Sources
List of Figures
Figure 1. Evolocumab Product Picture
Figure 2. Global Evolocumab Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Evolocumab Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Evolocumab Sales Status and Outlook (2024-2034) & (Kg)
Figure 5. Product Picture of Patent
Figure 6. Global Patent Sales YoY Growth (2024-2034) & (Kg)
Figure 7. Product Picture of Generic
Figure 8. Global Generic Sales YoY Growth (2024-2034) & (Kg)
Figure 9. Global Evolocumab Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Evolocumab Sales Market Share by Type in 2022 & 2034
Figure 11. North America Evolocumab Sales Market Share in Volume by Type in 2022
Figure 12. North America Evolocumab Sales Market Share in Value by Type in 2022
Figure 13. Europe Evolocumab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Evolocumab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Evolocumab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Evolocumab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Evolocumab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Evolocumab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Evolocumab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Evolocumab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Evolocumab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Evolocumab Revenue in 2022
Figure 23. Evolocumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Chemical
Figure 25. Global Chemical Sales YoY Growth (2024-2034) & (Kg)
Figure 26. Product Picture of Pharmaceutical
Figure 27. Global Pharmaceutical Sales YoY Growth (2024-2034) & (Kg)
Figure 28. Global Evolocumab Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Evolocumab Sales Market Share by Application in 2022 & 2034
Figure 30. North America Evolocumab Sales Market Share in Volume by Application in 2022
Figure 31. North America Evolocumab Sales Market Share in Value by Application in 2022
Figure 32. Europe Evolocumab Sales Market Share in Volume by Application in 2022
Figure 33. Europe Evolocumab Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Evolocumab Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Evolocumab Sales Market Share in Value by Application in 2022
Figure 36. Latin America Evolocumab Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Evolocumab Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Evolocumab Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Evolocumab Manufacturing Cost Structure
Figure 41. Evolocumab Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed